UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(dD) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): ~~April~~June 1715, 2007

Grant Life Sciences, Inc.

__________________________________________

(Exact name of registrant as specified in its charter)

Nevada	000-50133	82-0490737
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)

1787 East Ft. Union Blvd., Suite 202 Salt Lake City, Utah		84121
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: (801) ~~261~~733-~~8736~~0878

Copies to:

Gregory Sichenzia, Esq.

Yoel Goldfeder, Esq.

Sichenzia Ross Friedman Ference LLP

1065 Avenue of the Americas

New York, New York 10018

Phone: (212) 930-9700

Fax: (212) 930-9725

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 41.01. Entry into ~~Changes~~a inMaterial ~~Registrant's~~Definitive ~~Certifying Accountant.~~Agreement

OnTo ~~April~~obtain ~~17,~~funding ~~2007~~for its ongoing operations, Grant Life Sciences, Inc. ~~dismissed~~(the “Company”) entered into ~~Singer~~a ~~Lewak~~Securities ~~Greenbaum~~Purchase ~~& Goldstein~~Agreement ~~LLP~~(the as“Agreement”) ~~its~~with ~~independent~~New ~~registered~~Millennium Capital ~~public~~Partners ~~accounting~~II, ~~firm~~LLC, AJW Master Fund, Ltd. ~~Effective~~and AJW Partners, LLC ~~April~~(collectively, 17the “Investors”) on June 15, 2007 for the sale of (i) $500,000 wein callable ~~engaged~~secured ~~Tanner~~convertible LCnotes as(the ~~our~~“Notes”) ~~new~~and ~~independent~~(ii) ~~registered~~stock ~~public~~purchase ~~accounting~~warrants ~~firm.~~(the ~~Our~~“Warrants”) ~~board~~to ofbuy ~~directors~~10,000,000 ~~has~~shares ~~approved~~of ~~the~~our ~~dismissal~~common ofstock. ~~Singer~~On June ~~Lewak~~15, ~~Greenbaum~~2007, &the ~~Goldstein~~Investors ~~LLP~~purchased $500,000 in Notes and ~~the~~received ~~appointment~~Warrants to purchase 10,000,000 shares of ~~Tanner~~the LCCompany’s ascommon ~~our~~stock. ~~new~~The Company received ~~independent~~net ~~registered~~proceeds ~~public~~of ~~accounting~~$455,000.00, ~~firm~~after deducting expenses of $45,000.00.

~~From~~The ~~the~~Notes ~~date~~bear ofinterest ~~Singer~~at ~~Lewak~~8%, ~~Greenbaum~~mature &three ~~Goldstein~~years ~~LLP's~~from ~~appointment through~~ the date of ~~their dismissal on April 17~~issuance, ~~2007,~~and ~~there were no disagreements between~~are ~~our~~convertible ~~company~~into ~~and~~our ~~Singer~~common ~~Lewak~~stock, ~~Greenbaum~~at &the ~~Goldstein~~Investors' ~~LLP~~option, onat ~~any~~a ~~matter listed~~conversion ~~under~~price ~~Item~~equal ~~304~~to ~~Section~~the lower of (ai)~~(1)(iv)~~ A$0.15 toor E(ii) 60% of ~~Regulation~~the ~~S-B,~~average ~~including~~of ~~accounting~~the three ~~principles~~lowest orintraday ~~practices,~~trading ~~financial~~prices ~~statement~~for ~~disclosure~~our orcommon ~~auditing~~stock ~~scope~~during orthe 20 trading days ~~procedure which~~before, ifbut not ~~resolved~~including, to the ~~satisfaction~~conversion date. As of ~~Singer~~June ~~Lewak~~15, ~~Greenbaum~~2007, the average &of ~~Goldstein~~the ~~LLP~~three ~~would~~lowest ~~have~~intraday ~~caused~~trading ~~Singer~~prices ~~Lewak~~for ~~Greenbaum~~our &common ~~Goldstein~~stock ~~LLP~~during the topreceding ~~make~~20 ~~reference~~trading todays ~~the~~as ~~matter~~reported ~~in its reports~~ on ~~our~~the ~~financial~~Over-The-Counter ~~statements.~~Bulletin Board ~~The~~was ~~report~~$0.0225 onand, therefore, the ~~financial~~conversion ~~statements~~price ~~prepared~~for bythe ~~Singer~~secured ~~Lewak~~convertible ~~Greenbaum &~~notes ~~Goldstein~~ was ~~LLP~~$0.0135. ~~for~~Based ~~the~~on ~~year~~this ~~ended~~conversion ~~December 31~~price, ~~2006~~the ~~contained~~$500,000 aNotes, ~~paragraph setting~~excluding ~~forth~~interest, ~~that~~were ~~there~~convertible ~~was~~into ~~substantial~~37,037,037 ~~doubt~~shares asof to our ~~ability~~common ~~to continue as a going concern~~stock.

~~Prior~~We tomay ~~engaging~~prepay ~~Tanner~~the LCNotes in the event that no event of default exists, there are a sufficient number of shares available for conversion of the callable secured convertible notes and the market price is at or below $.40 per share. The full principal amount of the Notes is due upon default under the terms of Notes. In addition, we ~~did~~have ~~not~~granted ~~consult~~the ~~Tanner~~Investors LCa ~~regarding~~security ~~either:~~interest in substantially all of our assets and intellectual property as well as registration rights.

1.The Warrants ~~the~~are ~~application~~exercisable ofuntil ~~accounting~~seven ~~principles~~years tofrom ~~any specified transaction, either completed or proposed, or~~ the ~~type~~date of ~~audit~~issuance ~~opinion~~at ~~that~~a purchase ~~might~~price beof ~~rendered~~$.05 onper ~~our~~share. ~~financial~~In ~~statements~~addition, ~~and~~the ~~neither~~exercise aprice ~~written~~of ~~report~~the Warrants ~~was~~is ~~provided~~adjusted toin ~~our~~the ~~company~~event ~~nor~~we ~~oral~~issue ~~advice~~common ~~was~~stock ~~provided~~at ~~by Tanner LC that was an important factor considered by our company in reaching~~ a ~~decision~~price asbelow ~~to the accounting, auditing or financial reporting issue; or~~market.

2.The Investors ~~any~~have ~~matter~~contractually ~~that~~agreed ~~was~~to ~~either~~restrict ~~the~~their ~~subject~~ability ofto ~~disagreement~~convert orthe Notes ~~event,~~and asexercise ~~defined~~the inWarrants ~~Item~~and ~~304(a)(1)(iv)(A)~~receive shares of ~~Regulation~~our ~~S-B~~common ~~and~~stock such that the ~~related~~number ~~instruction~~of toshares ~~Item~~of ~~304~~the ofCompany ~~Regulation~~common ~~S-B,~~stock held by them and their affiliates after such conversion or aexercise ~~reportable~~does ~~event,~~not asexceed ~~that~~4.99% ~~term~~of isthe Company’s ~~explained~~then inissued ~~Item~~and ~~304(a)(1)(iv)(A)~~outstanding shares of ~~Regulation~~common ~~S-B~~stock.

~~Prior to engaging~~Item ~~Tanner~~2.03 ~~LC,~~Creation ~~Tanner~~of LCa ~~has~~Direct ~~not~~Financial ~~provided~~Obligation ~~our company with either written~~ or ~~oral~~an ~~advice~~Obligation ~~that~~Under ~~was~~ an ~~important~~Off-Balance ~~factor~~Sheet ~~considered~~Arrangement byof ~~our company in reaching~~ a ~~decision to change our independent registered public accounting firm from Singer Lewak Greenbaum & Goldstein LLP to Tanner LC.~~Registrant

WeThe ~~provided~~sale of ~~Singer~~the ~~Lewak~~Notes ~~Greenbaum~~described &in ~~Goldstein~~Item ~~LLP~~1.01 ~~with~~was acompleted ~~copy of this Current Report~~ on ~~Form~~June ~~8-K on April 17~~15, 2007,. As ~~prior~~of the todate ~~its~~hereof, ~~filing with~~ the ~~SEC,~~Company ~~and requested~~is ~~that~~obligated ~~they~~on ~~furnish~~$500,000 usin ~~with~~face aamount ~~letter~~of ~~addressed~~Notes issued to the ~~SEC~~Investors. ~~stating whether~~The ~~they~~Notes ~~agree~~are ~~with~~a ~~the~~debt ~~statements~~obligation ~~made~~arising inother ~~this Current Report on Form~~than ~~8-K,~~in ~~and if not, stating~~ the ~~aspects~~ordinary ~~with~~course ~~which they do not agree. A copy~~ of ~~the letter~~business ~~provided~~which byconstitute ~~Singer~~a ~~Lewak~~direct ~~Greenbaum~~financial ~~& Goldstein LLP, dated April 17,~~obligation ~~2007,~~of isthe ~~attached to this Form 8-K as an exhibit~~Company.

~~ITEM~~Item 93.~~01 Financial~~02 Unregistered ~~Statements~~Sales ~~and~~of ~~Exhibits~~Equity Securities

Exhibit Number		Description
16.1		Letter from Singer Lewak Greenbaum & Goldstein LLP, dated April 17, 2007.

The Notes and Warrants described in Item 1.01 were offered and sold to the Investors in a private placement transaction made in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933 and Rule 506 promulgated thereunder. Each of the Investors is an accredited investor as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933.

Item 9.01 Financial Statements and Exhibits

Exhibit No.	Description

10.1	Securities Purchase Agreement dated June 15, 2007 by and among the Company and New Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW Partners, LLC
10.2	Form of Callable Secured Convertible Note dated June 15, 2007
10.3	Form of Stock Purchase Warrant dated June 15, 2007
10.4	Registration Rights Agreement dated June 15, 2007 by and among the Company and New Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW Partners, LLC

10.5	Security Agreement dated June 15, 2007 by and among the Company and New Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW Partners, LLC
10.6	Intellectual Property Security Agreement dated June 15, 2007 by and among the Company and New Millennium Capital Partners II, LLC, AJW Master Fund, Ltd. and AJW Partners, LLC

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Grant Life Sciences, Inc.
Date: April 23, 2007	By:	/s/ Doyle R. Judd
Date: June 22, 2007	By:	/s/Doyle R. Judd
		Name: Doyle R. Judd Title: Chief Financial Officer
		Name: Doyle R. Judd
		Title: Chief Financial Officer

Filing Compare · Grant Life Sciences, Inc.